M. Treur

Efficacy of Recombinant Activated Factor VII (rFVIIa) vs. Activated Prothrombin Complex Concentrate (APCC) in Patients with Hemophilia with Inhibitors: A Bayesian Meta-Analysis.

A. Joshi, F. D. Charro, B. Heeg, 2007 .

Cost-Effectiveness Analysis of Aripiprazole Augmentation Treatment of Patients with Major Depressive Disorder Compared to Olanzapine and Quetiapine Augmentation in Turkey: A Microsimulation Approach.

H. Savaş, B. Heeg, N. Dilbaz, 2013, Value in health regional issues.

Treatment Sequencing Survival Model for Patients with Multiple Myeloma Ineligible for Stem Cell Transplantation (SCT).

U. Mellqvist, H. Einsele, A. Palumbo, 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Long-Term Outcomes and Treatment Patterns in Patients with Symptomatic Multiple Myeloma in the Real-World Setting: A Retrospective Analysis of the Czech Rmg Registry

R. Hájek, W. Bouwmeester, M. Campioni, 2016 .

The use and impact of value of information analysis in decision-making

B. Heeg, A. Filonenko, L. Chuang, 2013 .

Treatment Sequencing Survival Model for Patients with Multiple Myeloma Ineligible for Stem Cell Transplantation (SCT).

U. Mellqvist, H. Einsele, P. Sonneveld, 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Efficacy of recombinant activated factor VII vs. activated prothrombin complex concentrate for patients suffering from haemophilia complicated with inhibitors: a Bayesian meta‐regression

F. D. de Charro, B. van Hout, M. Botteman, 2009, Haemophilia : the official journal of the World Federation of Hemophilia.